Clinical Trial Update: The Women TDF-FTC Benchmark Study [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for the Women TDF-FTC Benchmark Study evaluating HIV prevention; the study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• TDF-FTC (tenofovir disoproxil fumarate/emtricitabine) (tenofovir disoproxil fumarate and emtricitabine)

Snippet

Sponsor: University of Washington | Conditions: HIV Infections | Phase 2 | Status: ACTIVE_NOT_RECRUITING